Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1785131

Cc1ccccc1-c1cccc(C(N)=O)c1.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 2/20 0.51
PDK2 Q15119 1/20 0.50
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
FFAR1 O14842 1/20 0.47
BAZ2B Q9UIF8 1/20 0.47
BAZ2A Q9UIF9 1/20 0.47
PARP1 P09874 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
MCL1 Q07820 1/20 0.43
SHMT1 P34896 1/20 0.43
F10 P00742 2/20 0.43
PRSS1 P07477 2/20 0.43
F2 P00734 2/20 0.43
BRD4 O60885 1/20 0.43
LRRK2 Q5S007 1/20 0.42
DHODH Q02127 1/20 0.42
DPP4 P27487 1/20 0.42
DPP8 Q6V1X1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5067781 0.90 AKR1C3 (0.46) NR1H4PDK2AKR1C3AKR1C2FFAR1
SCHEMBL3636122 0.90 NR1H4 (0.56) NR1H4PDK2FFAR1BAZ2BBAZ2A
Trifluoroacetic Acid SCHEMBL30687977 0.84 DHODH (0.58) PDK2PARP1PRSS1DHODHDPP4
Trifluoroacetic Acid SCHEMBL7759604 0.84 DHODH (0.58) PDK2PARP1PRSS1DHODHDPP4
SCHEMBL3135455 0.79 PARP1 (0.53) NR1H4BAZ2BBAZ2APARP1BRD4
SCHEMBL2995452 0.79 NR1H4 (0.74) NR1H4AKR1C3AKR1C2FFAR1NPC1
SCHEMBL5307077 0.78 PARP1 (0.56) PDK2BAZ2BBAZ2APARP1NPC1
Trifluoroacetic Acid SCHEMBL10277408 0.78 PARP1 (0.59) PARP1DHODH
Trifluoroacetic Acid SCHEMBL29713373 0.78 PARP1 (0.59) PARP1DHODH
Hydrochloric Acid SCHEMBL29287827 0.78 PARP1 (0.51) NR1H4BAZ2BBAZ2APARP1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110124559-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124559-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS OPRL1, OPRM1, OPRK1 NR1H4 228/4885PDK2 4021/4885AKR1C3 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.